Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 and up

Optimising high-flow oxygen settings in hypoxemic distress using depth-camera lung-volume measurements

Official title: Optimisation of High Flow Oxygen Therapy Settings During Hypoxaemic Respiratory Distress Based on Non-contact Measurement of Lung Volumes by Depth Camera

Run by University Hospital, Brest · NCT06819644 · Data updated 2026-11-12

This trial tests whether adjusting high-flow oxygen delivery based on lung volumes measured by a depth camera can reduce the need for intubation in ICU patients with hypoxemic respiratory failure.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment406 (estimated)
SponsorUniversity Hospital, Brest
Academic / other
Locations8 sites (Brest and 7 other locations)
StatusRecruiting
StartedApril 8, 2026
Main results expectedOctober 2030
Study endsOctober 2030
Registry record updatedJune 29, 2026
Trial IDNCT06819644 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with hypoxemic respiratory distress requiring high-flow oxygen in the ICU, without prior chronic respiratory failure and without contraindications to non-invasive ventilation.

Probably not a fit

Patients with conditions unlikely to respond to optimized HFO or those who rapidly deteriorate may not benefit from the approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this phase 3 interventional trial, adults with hypoxemic respiratory distress in the ICU are randomized to receive high-flow oxygen either by standard practice or with ventilatory parameters adjusted according to lung volumes measured non-invasively by a depth-camera system. The depth camera tracks chest and abdominal movements to estimate lung volume, respiratory rate, and symmetry, guiding oxygen flow. The goal is to see if this measurement-guided approach lowers the intubation rate and improves oxygenation compared with conventional care. The study uses a non-contact method to obtain physiological data, integrating it into the HFO management algorithm. Primary outcomes focus on need for intubation; secondary outcomes may include oxygenation metrics and safety.

Why it matters

Potential benefit: If successful, patients could have a lower risk of intubation and better oxygenation with personalized HFO settings.

How similar studies have gone: Previous small studies using non-invasive lung-volume estimation technologies have shown feasibility, but this approach in a randomized phase 3 trial is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with hypoxemic respiratory distress define by the following 4 criteria:
* Respiratory rate ≥ 25 breaths per minutes
* A ratio of the partial pressure of arterial oxygen (PaO2) to the FiO2 ≤ 300 mmHg while the patient is breathing oxygen at a flow rate of 10 liters per minutes or more
* A partial pressure of arterial carbon dioxide (PaCO2) not higher than 45 mmHg
* An absence of clinical history of underlying chronic respiratory failure

Exclusion Criteria:

* A do-not-intubate order
* Pregnant or lactating woman
* Cardiogenic pulmonary edema
* Exacerbation of asthma
* Hemodynamic instability with use of vasopressor at significant dose (norepinephrine \> 0.5 mg/h)
* A Glasgow Coma Scale of 12 points of less
* Contraindications to non-invasive ventilation
* Urgent need for endotracheal intubation
* High flow oxygen therapy started within 48 hours before inclusion
* Patient under legal protection or deprived of liberty

Where it's running

  • Brest, University Hospital
    Brest, France
    Recruiting
  • AP-HP - Hôpital Louis Mourier
    Colombes, France
    Not yet recruiting
  • AP-HP - Hôpital Henri Mondor
    Créteil, France
    Not yet recruiting
  • CH Morlaix
    Morlaix, France
    Not yet recruiting
  • CHR Orléans
    Orléans, France
    Not yet recruiting
  • CH Poitiers
    Poitiers, France
    Not yet recruiting
Show 2 more locations
  • CHU Rennes
    Rennes, France
    Not yet recruiting
  • CHU Tours
    Tours, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.